AzTrials
AzTrials

Neck PainMTPNCT06267755

Efficacy of Extracorporeal Shockwave Therapy on Ultrasonography Changes of Upper Trapezius Myofascial Trigger Points in Patients With Non Specific Neck Pain

A study testing Extracorporeal Shockwave therapy and Traditional physical therapy in people with Neck Pain, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

this study will be conducted to investigate the effect of Extracorporeal Shockwave Therapy on Ultrasonography Changes of Upper Trapezius Myofascial Trigger Points in Patients With Non Specific Neck Pain Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Neck Pain
What is being tested?
Extracorporeal Shockwave therapy and Traditional physical therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
20 Feb 2024to 30 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Sixty patients receiving a diagnosis of non-specific neck pain with upper trapezius myofascial trigger points by an orthopaedist physician.
  • Body mass index of participants was normal less than (30 kg/m2)(Al-asadi, 2018).
  • Age over 18 years.
  • Presence of taught band.
  • Presence of hyper irritable spot in a taught band, and reproduction of the typical referred pain pattern of the myofascial trigger point in response to compression

Who cannot join

  • Having signs and symptoms of neurological disorders that cause nerve root compression.
  • Headache as a consequence of specific headache diagnosis.
  • Having a history of specific signs of malignancy, or infection.
  • Having a history of trauma with or without proven structural disorders in the region of the neck, shoulder, and head (e.g. whiplash).
  • Having signs and symptoms of cerebrovascular insufficiency.
  • Having a severe chronic disease of the locomotor system (e.g. polyarthritis, muscular disease
  • Any participant with contraindications to shock wave therapy

Trial locations and contacts

No sites are listed yet.

Mahmoud Fouad, master contact

01227740639

mahmoud.adel27392@gmail.com

Maher El keblawy, professor contact

01001419544

katyary@yahoo.com

About this study

this study will be conducted to investigate the effect of Extracorporeal Shockwave Therapy on Ultrasonography Changes of Upper Trapezius Myofascial Trigger Points in Patients With Non Specific Neck Pain

Read the detailed description

Neck pain is one of the most commonly reported musculoskeletal disorders. The prevalence for neck pain varies between 16.7% and 75.1% in the general population. Up to 67% of world's population may present chronic non-specific neck pain at least once in their lives. The upper trapezius is probably the muscle most often beset by trigger points, it is indicated that the upper trapezius is the most sensitive of 8 different muscles (upper trapezius, pectoralis major, levator scapulae, teres major, supraspinatus, gluteus medius, infraspinatus, paraspinal) to the pressure of an algometer.Recently, the extracorporeal shock wave has been widely known to be an effective therapeutic modality in myofascial pain syndrome treatment and a systematic review provided promising insight into the effectiveness of ESWT in Myofascial pain syndrome treatment. sixty patients with non specific neck pain will be assigned randomly to two groups; first one will receive shock wave therapy and traditional therapy and the second one will receive traditional therapy only for six weeks.

Conditions
Neck Pain
Being tested
Extracorporeal Shockwave therapy, Traditional physical therapy
Keywords
Extracorporeal Shockwave Therapy, Ultrasonography Changes, Non Specific Neck Pain
Medical subject headings
Neck Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Extracorporeal Shockwave therapyOther

    the patients will receive Extracorporeal Shockwave therapy sessions by 600 impulses with 1.6 bar pressure at a frequency of 8 Hz on site of the upper trapezius

  • Traditional physical therapyOther

    the patients will receive Traditional physical therapy in the form of Integrated neuro-muscular inhibition technique + posture correction and scapular stabilization exercises.

Study groups in NCT06267755
Study groupRoleWhat they receive
Extracorporeal Shockwave therapyExperimentalThirty patients will receive Extracorporeal Shockwave therapy and Traditional physical therapy three times per week for six consecutive weeks.
Receives: Other: Extracorporeal Shockwave therapy; Other: Traditional physical therapy
Traditional physical therapyActive comparatorThirty patients will receive Traditional physical therapy three times per week for six consecutive weeks.
Receives: Other: Traditional physical therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. muscle thickness

    Ultrasonography device will be used to assess muscle thickness

    Measured: up to six weeks

  2. hypoechoic area intensity

    An ultrasonography device will be used to assess the hypoechoic area intensity

    Measured: up to six weeks

Secondary outcomes (4)
  1. neck disability

    Arabic version of neck disability index will be used to measure neck disability. It consists of 10 questions: pain intensity, personal care, lifting, reading, headaches, concentration, work, driving, sleeping, and recreation. 5 Each item is scored from 0 (no disability) to 5 (total disability). The maximum possible score is 50.

    Measured: up to six weeks

  2. pressure pain threshold

    Digital algometer will be used to measure pressure pain threshold

    Measured: up to six weeks

  3. cervical range of motion

    The cervical range of motion (CROM) device will be used to measure cervical ROM

    Measured: up to six weeks

  4. pain intensity

    The visual analog scale (VAS) will be used to measure pain intensity. it is a10 cm line, oriented vertically or horizontally, with one end representing "no pain" and the other end representing pain as bad as it can be

    Measured: up to six weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2024
  2. Study start20 Feb 2024 (estimated)
  3. Primary completion30 Aug 2024 (estimated)
  4. Study completion30 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
extracorporeal shockwave and traditional therapy
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06267755
Sponsor's protocol ID
P.T.REC/012/004884
Acronym
MTP
Status last verified
Feb 2024
First submitted
12 Feb 2024
Last updated
20 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Extracorporeal Shockwave therapy and Traditional physical therapy in people with Neck Pain, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mahmoud Fouad, master (01227740639, mahmoud.adel27392@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

muscle thickness (time frame: up to six weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in